Literature DB >> 29515051

Circulating Oxidized Low-Density Lipoprotein Levels Independently Predict 10-Year Progression of Subclinical Carotid Atherosclerosis: A Community-Based Cohort Study.

Shen Gao1, Dong Zhao1, Yue Qi1, Wei Wang1, Miao Wang1, Jiayi Sun1, Jun Liu1, Yan Li1, Jing Liu1.   

Abstract

AIMS: To investigate the association between circulating oxidized low-density lipoprotein (ox-LDL) levels and progression of subclinical atherosclerosis and to examine whether this link is independent of other low-density lipoprotein (LDL)-related parameters.
METHODS: Totally, 804 subjects who were free of cardiovascular disease at baseline completed risk factor surveys and carotid ultrasound measurements in 2002 and 2012. Modified Poisson regression was performed to examine the association between baseline serum ox-LDL levels and the 10-year risk of progression of carotid atherosclerosis which was defined as the development of at least one new plaque in a previously plaque-free carotid segment at re-examination.
RESULTS: The mean age of the subjects was 58.6±7.7 years at baseline and 43.3% were men. A total of 504 (62.7%) subjects had carotid plaque progression at re-examination. Subjects in the intermediate and highest tertiles of ox-LDL had a significantly higher adjusted risk of atherosclerosis progression than those in the lowest tertile [relative risk (95% confidence interval) 1.17 (1.01-1.34) for the intermediate tertile and 1.23 (1.07-1.42) for the highest tertile]. This association was independent of baseline levels of LDL-C, total LDL particle number, and small LDL particle number.
CONCLUSION: This study demonstrates that serum ox-LDL levels predict 10-year progression of subclinical atherosclerosis. Moreover, this effect is independent of the cholesterol content, the number, and the size of LDL particles.

Entities:  

Keywords:  Atherosclerosis; Carotid stenosis; Cohort study; Oxidized low-density lipoprotein; Risk factors

Mesh:

Substances:

Year:  2018        PMID: 29515051      PMCID: PMC6193183          DOI: 10.5551/jat.43299

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  34 in total

1.  C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study.

Authors:  Irene M Van Der Meer; Moniek P M De Maat; A Elisabeth Hak; Amanda J Kiliaan; Antonio Iglesias Del Sol; Deirdre A M Van Der Kuip; Rogier L G Nijhuis; Albert Hofman; Jacqueline C M Witteman
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

Authors:  J de Graaf; H L Hak-Lemmers; M P Hectors; P N Demacker; J C Hendriks; A F Stalenhoef
Journal:  Arterioscler Thromb       Date:  1991 Mar-Apr

Review 3.  Association Between Circulating Oxidized LDL and Atherosclerotic Cardiovascular Disease: A Meta-analysis of Observational Studies.

Authors:  Shen Gao; Dong Zhao; Miao Wang; Fan Zhao; Xueyu Han; Yue Qi; Jing Liu
Journal:  Can J Cardiol       Date:  2017-07-29       Impact factor: 5.223

4.  Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study.

Authors:  Wuxiang Xie; Jing Liu; Wei Wang; Miao Wang; Yue Qi; Fan Zhao; Jiayi Sun; Jun Liu; Yan Li; Dong Zhao
Journal:  Int J Cardiol       Date:  2016-04-16       Impact factor: 4.164

5.  Activation-dependent surface expression of LOX-1 in human platelets.

Authors:  M Chen; M Kakutani; T Naruko; M Ueda; S Narumiya; T Masaki; T Sawamura
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

6.  OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.

Authors:  Sungwoo Ryoo; Anil Bhunia; Fumin Chang; Artin Shoukas; Dan E Berkowitz; Lewis H Romer
Journal:  Atherosclerosis       Date:  2010-11-04       Impact factor: 5.162

Review 7.  LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.

Authors:  Naga Venkata K Pothineni; Sotirios K Karathanasis; Zufeng Ding; Arockiasamy Arulandu; Kottayil I Varughese; Jawahar L Mehta
Journal:  J Am Coll Cardiol       Date:  2017-06-06       Impact factor: 24.094

8.  Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.

Authors:  Kelly J Hunt; Nathaniel Baker; Patricia Cleary; Jye-Yu Backlund; Timothy Lyons; Alicia Jenkins; Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2013-10-11       Impact factor: 5.162

9.  LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells.

Authors:  Dayuan Li; Ling Liu; Hongjiang Chen; Tatsuya Sawamura; Subramanian Ranganathan; Jawahar L Mehta
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

10.  MicroRNA hsa-let-7g targets lectin-like oxidized low-density lipoprotein receptor-1 expression and inhibits apoptosis in human smooth muscle cells.

Authors:  Zufeng Ding; Xianwei Wang; Magomed Khaidakov; Shijie Liu; Jawahar L Mehta
Journal:  Exp Biol Med (Maywood)       Date:  2012-09-06
View more
  3 in total

1.  An Intriguing and Important Concept Relevant to Oxidized Low-Density Lipoprotein and Atherogenesis is Still Problematic for its Contribution to the Better Understanding of Clinical Atherosclerosis.

Authors:  Hiroshi Yoshida
Journal:  J Atheroscler Thromb       Date:  2018-08-02       Impact factor: 4.928

2.  Apolipoprotein B/A1 Ratio Is Associated with Severity of Coronary Artery Stenosis in CAD Patients but Not in Non-CAD Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Rui Hua; Yijun Li; Wenyuan Li; Zhen Wei; Zuyi Yuan; Juan Zhou
Journal:  Dis Markers       Date:  2021-12-18       Impact factor: 3.434

3.  High sdLDL Cholesterol can be Used to Reclassify Individuals with Low Cardiovascular Risk for Early Intervention: Findings from the Chinese Multi-Provincial Cohort Study.

Authors:  Yue Qi; Jing Liu; Wei Wang; Miao Wang; Fan Zhao; Jiayi Sun; Jun Liu; Qiuju Deng; Dong Zhao
Journal:  J Atheroscler Thromb       Date:  2019-10-30       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.